DIN 02521679 — NGENLA 20 MG
NGENLA is a solution of Somatrogon marketed by PFIZER CANADA ULC. The full Somatrogon monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02521679
- Brand name
- NGENLA
- Active ingredient
- Somatrogon
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Long-acting human growth hormone analogue (CTP-modified)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Somatrogon products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02521687 | NGENLA | 50 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |